CN Stock MarketDetailed Quotes

603439 Guizhou Sanli Pharmaceutical Co.,Ltd.

Watchlist
  • 15.66
  • +0.62+4.12%
Market Closed Apr 30 15:00 CST
6.42BMarket Cap21.84P/E (TTM)

Guizhou Sanli Pharmaceutical Co.,Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guizhou Sanli Pharmaceutical Co.,Ltd. Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 27, 2024

Revenue(YoY)

422.02M

+20.93%
EPS(YoY)

0.14

+7.69%
Analyst Rating

Strong Buy

May 3, 2024

Guizhou Sanli Pharmaceutical Co.,Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.731B--
--2024/FY-- / 2.204B--
--2023/FY1.635B / 1.560B--
--2022/FY1.201B / 1.204B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.731B--
--2024/FY-- / 2.204B--
--2023/FY1.635B / 1.560B--
--2022/FY1.201B / 1.204B--

Guizhou Sanli Pharmaceutical Co.,Ltd. Earnings Reports

  • 2024 First Quarter Report

    Apr 26 12:00 ET

  • 2023 ANNUAL REPORT

    Apr 26 12:00 ET

  • 2023 Annual Report Summary

    Apr 26 12:00 ET

  • Guizhou Sanli Pharmaceutical Co., Ltd. 2023 Annual Results Forecast

    Jan 9 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 3, 2024

    Strong Buy

    • Strong Buy

      62.50%

    • Buy

      37.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg